On May 31, 2023, Altamira Therapeutics Ltd., closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +19.58% | +9.62% | -50.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.86% | 3.99M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CYTO Stock
- News Altamira Therapeutics Ltd.
- Altamira Therapeutics Ltd. announced that it has received CHF 2.5 million in funding from FiveT Investment Management Ltd.